Literature DB >> 11912141

Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.

Yi Zhou1, Fuad G Gwadry, William C Reinhold, Lance D Miller, Lawrence H Smith, Uwe Scherf, Edison T Liu, Kurt W Kohn, Yves Pommier, John N Weinstein.   

Abstract

cDNA microarray technology can be used to establish associations between characteristic gene expression patterns and molecular responses to drug therapy. In this study, we used cDNA microarrays of 1694 cancer-related genes to monitor the gene expression consequences of the treatment of HCT116 colon cancer cells with the topoisomerase I inhibitor camptothecin (CPT). To obtain a more homogeneous cellular response, we synchronized the cells in S-phase using aphidicolin (APH) before CPT treatment. Brief incubation with 20 and 1000 nM CPT caused reversible and irreversible G(2) arrest, respectively, and the patterns of gene expression change (with reference to untreated controls) were strikingly different at the two concentrations. Thirty-three genes, mainly divided into three groups, showed characteristic changes in the first 20 h as a consequence of treatment. Northern blots performed for five of these genes (each under eight experimental conditions) were quite consistent with the microarray results (average correlation coefficient, 0.86). Several p53-activated stress response genes were up-regulated after treatment with 1000 nM CPT or prolonged exposure to APH, but it seemed that the up-regulation did not directly cause cell cycle arrest because the up-regulation induced by prolonged treatment with APH did not prevent cell cycle progression after removal of APH. In contrast, cell cycle-dependent up-regulation of a group of mitosis-related genes was delayed or blocked after CPT treatments. The interrupted up-regulation of this group of genes was directly associated with G(2) arrest. In addition, we observed down-regulation of gene expression in cells that were recovering from cell cycle delay. The observations reported here suggest a fundamental difference at the gene expression level between the molecular mechanism of reversible G(2) delay that follows mild DNA damage and the mechanism of permanent G(2) arrest that follows more extensive DNA damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912141

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip.

Authors:  Shen-Hua Xu; Li-Juan Qian; Han-Zhou Mou; Chi-Hong Zhu; Xing-Ming Zhou; Xiang-Lin Liu; Yong Chen; Wen-Yu Bao
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

2.  Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines.

Authors:  Anna T Rogojina; William E Orr; Bong K Song; Eldon E Geisert
Journal:  Mol Vis       Date:  2003-10-06       Impact factor: 2.367

3.  RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors.

Authors:  S E Martin; Z-H Wu; K Gehlhaus; T L Jones; Y-W Zhang; R Guha; S Miyamoto; Y Pommier; N J Caplen
Journal:  Curr Cancer Drug Targets       Date:  2011-10       Impact factor: 3.428

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

5.  Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.

Authors:  Kimberly J Bussey; Koei Chin; Samir Lababidi; Mark Reimers; William C Reinhold; Wen-Lin Kuo; Fuad Gwadry; Hosein Kouros-Mehr; Jane Fridlyand; Ajay Jain; Colin Collins; Satoshi Nishizuka; Giovanni Tonon; Anna Roschke; Kristen Gehlhaus; Ilan Kirsch; Dominic A Scudiero; Joe W Gray; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2006-04       Impact factor: 6.261

6.  In vivo topoisomerase I inhibition attenuates the expression of hypoxia-inducible factor 1α target genes and decreases tumor angiogenesis.

Authors:  Eric Guérin; Wolfgang Raffelsberger; Erwan Pencreach; Armin Maier; Agnès Neuville; Anne Schneider; Philippe Bachellier; Serge Rohr; Amélie Petitprez; Olivier Poch; Dino Moras; Pierre Oudet; Annette K Larsen; Marie-Pierre Gaub; Dominique Guenot
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

7.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

8.  Transcriptome analysis of Aspergillus nidulans exposed to camptothecin-induced DNA damage.

Authors:  Iran Malavazi; Marcela Savoldi; Sônia Marli Zingaretti Di Mauro; Carlos Frederico Martins Menck; Steven D Harris; Maria Helena de Souza Goldman; Gustavo Henrique Goldman
Journal:  Eukaryot Cell       Date:  2006-10

9.  Recql5 plays an important role in DNA replication and cell survival after camptothecin treatment.

Authors:  Yiduo Hu; Xincheng Lu; Guangjin Zhou; Ellen L Barnes; Guangbin Luo
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

10.  Two-stage normalization using background intensities in cDNA microarray data.

Authors:  Dankyu Yoon; Sung-Gon Yi; Ju-Han Kim; Taesung Park
Journal:  BMC Bioinformatics       Date:  2004-07-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.